Schering-Plough Climbs Out of Its Sick Bed: http://www.businessweek.com/magazine/content/07_20/b4034076.htm
BusinessWeek - 5/4/07

New Critical Path Report Highlights Research Needed to Foster Generic Drug Development: http://www.fiercebiotech.com/node/6754
FierceBiotech - 5/3/07

Rituxan shows promise as possible MS treatment: http://www.marketwatch.com/news/story/rituxan-shows-promise-possible-ms/story.aspx?guid=%7BCDAFEC2B-4B51-4DF3-9CA9-C3D185EF2569%7D
MarketWatch - 5/1/07

Senate Takes Up Bill to Change Drug Agency Operations: http://www.nytimes.com/2007/05/01/washington/01drug.html?_r=1&oref=slogin
New York Times - 5/1/07

Congress Seeks Compromise on Generic Drugs: http://www.nytimes.com/2007/04/08/washington/08drug.html?adxnnl=1&adxnnlx=1176178073-IOrU6hN7VT/efaeGrLso0A
NY Times - 4/8/07

Out of the Gate: ImClone Systems: http://www.boston.com/business/technology/biotechnology/articles/2007/04/04/out_of_the_gate_imclone_systems/
The Boston Globe - 4/4/07

Roche buys BioVeris for $600 Million: biz.yahoo.com/seekingalpha/070405/31597_id.html?.v=1
Yahoo Business - 4/4/07

Patent office throws out key stem cell patents: http://milwaukee.bizjournals.com/milwaukee/stories/2007/04/02/daily15.html?jst=b_ln_hl
Milwaukee Business Journal - 4/3/07

Merck Diabetes Drug Cleared: http://www.thestreet.com/_googlen/newsanalysis/pharmaceuticals/10348003.html?cm_ven=GOOGLEN&cm_cat=FREE&cm_ite=NA
TheStreet.com - 4/2/07

Dendreon Decision Could Mean FDA Shift: http://www.forbes.com/sciencesandmedicine/2007/03/30/dendreon-provenge-fda-biz-sci_cx_mh_0330dendreon.html
Forbes - 3/30/07